Department of Pulmonary and Critical Care Medicine, Hengyang Medical School, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, 410004, China.
Department of Pediatric, The Third Xiangya Hosptial, Central South University, Changsha, 410013, China.
BMC Public Health. 2024 Sep 30;24(1):2670. doi: 10.1186/s12889-024-20185-6.
The relationship between vitamin D3 and asthma remains controversial. However, previous studies have largely overlooked the impact of epi-25-(OH)-vitamin D3. This study aims to investigate the effects of different forms of vitamin D3 on asthma attack in adults.
In this cross-sectional study, a total of 3,873 eligible adult participants were extracted from the national health and nutrition examination survey (NHANES) database from 2007 to 2018. Based on quartiles method, different levels of vitamin D were divided into four groups (Quartile 1-4). Bivariate correlation analysis was performed for vitamin D and covariates to avoid multicollinearity. Multivariate logistic regression was used to investigate the association between serum levels of vitamin D3 (epi-25-(OH)-vitamin D3 and 25-(OH)-vitamin D3) and asthma attack, adjusting for covariates including age, gender, race, length of time in the U.S., house poverty income ratio (PIR), education level, smoking history, hypertension history, and diabetes history. The ratio of epi-25-(OH)-vitamin D3 to 25-(OH)-vitamin D3 was used for secondary analysis of its association with asthma attack. The outcomes were assessed by odds ratios (ORs) and 95% confidence intervals (CIs).
Among the 3,873 eligible adults American with asthma, 1,508 (38.94%) had experienced at least one acute asthma attack in the past year. There was no significant correlation between vitamin D and covariates. After adjusting for covariates including age, gender, race, length of time in the U.S., house poverty income ratio (PIR), education level, smoking history, hypertension history and diabetes history, we found a positive correlation between the ratio of epi-25-(OH)-vitamin D3 to 25-(OH)-vitamin D3 and asthma attack. Additionally, a high ratio of epi-25-(OH)-vitamin D3 to 25-(OH)-vitamin D3 was more common among elder, male, of normal weight, non-Hispanic American, have a long time stay in the U.S., a high house PIR, and a history of hypertension individuals.
Our findings suggest that attention should be given to asthma attack associated with a high ratio of epi-25-(OH)-vitamin D3 to 25-(OH)-vitamin D3 in American adults who are elderly, male, of normal weight, non-Hispanic Americans, have long-term residence in the U.S., a high house PIR, and a history of hypertension.
维生素 D3 与哮喘之间的关系仍存在争议。然而,先前的研究在很大程度上忽略了 epi-25-(OH)-维生素 D3 的影响。本研究旨在探讨不同形式的维生素 D3 对成年人哮喘发作的影响。
在这项横断面研究中,我们从 2007 年至 2018 年的全国健康和营养检查调查(NHANES)数据库中提取了 3873 名符合条件的成年参与者。基于四分位数法,将不同水平的维生素 D 分为四组(四分位 1-4 组)。对维生素 D 和协变量进行双变量相关性分析,以避免共线性。采用多变量 logistic 回归分析血清维生素 D3(epi-25-(OH)-维生素 D3 和 25-(OH)-维生素 D3)水平与哮喘发作之间的关系,调整协变量包括年龄、性别、种族、留美时间、家庭贫困收入比(PIR)、教育水平、吸烟史、高血压史和糖尿病史。对 epi-25-(OH)-维生素 D3 与 25-(OH)-维生素 D3 的比值进行二次分析,以评估其与哮喘发作的关系。采用比值比(ORs)和 95%置信区间(CIs)评估结果。
在 3873 名患有哮喘的美国成年人中,有 1508 名(38.94%)在过去一年中至少经历过一次急性哮喘发作。维生素 D 与协变量之间无显著相关性。在校正包括年龄、性别、种族、留美时间、家庭贫困收入比(PIR)、教育水平、吸烟史、高血压史和糖尿病史在内的协变量后,我们发现 epi-25-(OH)-维生素 D3 与 25-(OH)-维生素 D3 的比值与哮喘发作呈正相关。此外,epi-25-(OH)-维生素 D3 与 25-(OH)-维生素 D3 的比值在年龄较大、男性、体重正常、非西班牙裔美国人、留美时间较长、家庭 PIR 较高和有高血压史的个体中更为常见。
我们的研究结果表明,在美国成年人中,应注意与 epi-25-(OH)-维生素 D3 与 25-(OH)-维生素 D3 的比值较高相关的哮喘发作,这些成年人年龄较大、男性、体重正常、非西班牙裔美国人、留美时间较长、家庭 PIR 较高和有高血压史。